6-aminonicotinamide has been researched along with Cell Transformation, Neoplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asara, JM; Choi, AM; Coloff, JL; Finkel, T; Henske, EP; Kwiatkowski, DJ; Locasale, JW; Malinowska, IA; Mizumura, K; Parkhitko, AA; Priolo, C; Wu, JJ; Xu, W; Yu, J; Yun, J | 1 |
1 other study(ies) available for 6-aminonicotinamide and Cell Transformation, Neoplastic
Article | Year |
---|---|
Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Animals; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 5; Beclin-1; Caspase 1; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cellular Reprogramming; Chloroquine; Enzyme Inhibitors; Glucose; Hydroxychloroquine; Lysosomal-Associated Membrane Protein 2; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred A; Mice, Transgenic; Microtubule-Associated Proteins; Mitochondria; Multiprotein Complexes; NF-kappa B; Oxygen Consumption; Pentose Phosphate Pathway; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Signal Transduction; Teratogens; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2014 |